Suppression of Pentosidine Formation in Galactosemic Rat Lens by an Inhibitor of Aldose Reductase
暂无分享,去创建一个
V. Monnier | R. Nagaraj | R H Nagaraj | V M Monnier | M Prabhakaram | B J Ortwerth | B. Ortwerth | M. Prabhakaram
[1] R. E. Perry,et al. Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats. , 1987, Experimental eye research.
[2] K. Bensch,et al. The role of ascorbic acid in senile cataract. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[3] V. Monnier,et al. Chromatographic Quantitation of Plasma and Erythrocyte Pentosidine in Diabetic and Uremic Subjects , 1992, Diabetes.
[4] A. Swaak,et al. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes. Possible mechanism in inflammation diseases. , 1984, The Journal of clinical investigation.
[5] P. Mclean,et al. The Effect of an Aldose Reductase Inhibitor (Sorbinil) on the Level of Metabolites in Lenses of Diabetic Rats , 1983, Diabetes.
[6] T. Lyons,et al. Role of Glycation in Modification of Lens Crystallins in Diabetic and Nondiabetic Senile Cataracts , 1991, Diabetes.
[7] S. Som,et al. Ascorbic acid metabolism in diabetes mellitus. , 1981, Metabolism: clinical and experimental.
[8] R. Blakytny,et al. Glycation (non-enzymic glycosylation) inactivates glutathione reductase. , 1992, The Biochemical journal.
[9] V. J. Stevens,et al. Diabetic cataract formation: potential role of glycosylation of lens crystallins. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[10] J. Kinoshita,et al. Aldose reductase in diabetic cataracts. , 1981, JAMA.
[11] V. Reddy,et al. Glutathione and its function in the lens--an overview. , 1990, Experimental eye research.
[12] A. Tappel,et al. Inactivation of ribonuclease and other enzymes by peroxidizing lipids and by malonaldehyde. , 1969, Biochemistry.
[13] D. Dvornik,et al. Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase Inhibitor , 1973, Science.
[14] A. Beyer-Mears,et al. Reversal of Diabetic Cataract by Sorbinil, an Aldose Reductase Inhibitor , 1985, Diabetes.
[15] S. Srivastava,et al. The transport of oxidized glutathione from human erythrocytes. , 1969, The Journal of biological chemistry.
[16] E. Abraham,et al. Glycation of human lens proteins: Preferential glycation of αA subunits☆ , 1992 .
[17] M. Lou,et al. Glutathione depletion in the lens of galactosemic and diabetic rats. , 1988, Experimental eye research.
[18] J. Kinoshita,et al. Sorbitol pathway in diabetic and galactosemic rat lens , 1974 .
[19] C. Waydhas,et al. Glutathione efflux from perfused rat liver after phenobarbital treatment, during drug oxidations, and in selenium deficiency. , 1978, European journal of biochemistry.
[20] L. Chylack,et al. Role of nonenzymatic glycosylation in experimental cataract formation. , 1980, Biochemical and biophysical research communications.
[21] B. Ortwerth,et al. Glutathione inhibits the glycation and crosslinking of lens proteins by ascorbic acid. , 1988, Experimental eye research.
[22] V. J. Stevens,et al. Nonenzymatic glycosylation, sulfhydryl oxidation, and aggregation of lens proteins in experimental sugar cataracts , 1979, The Journal of experimental medicine.
[23] B. S. Winkler,et al. In vitro oxidation of ascorbic acid and its prevention by GSH. , 1987, Biochimica et biophysica acta.
[24] J. Baynes,et al. Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. , 1991, The Journal of biological chemistry.
[25] A. Meister,et al. Inhibition of glutathione synthesis in the newborn rat: a model for endogenously produced oxidative stress. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[26] T. Kuwabara,et al. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study. , 1982, Investigative ophthalmology & visual science.
[27] B. Ortwerth,et al. The glycation-associated crosslinking of lens proteins by ascorbic acid is not mediated by oxygen free radicals. , 1991, Experimental eye research.
[28] H. Kern,et al. Transport of vitamin C in the lens. , 1987, Current eye research.
[29] V. Monnier,et al. Non-tryptophan fluorescence and high molecular weight protein formation in lens crystallins of rats with chronic galactosemia: prevention by the aldose reductase inhibitor sorbinil. , 1990, Experimental eye research.
[30] V. Monnier,et al. High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[31] V. Monnier,et al. Nonenzymatic browning in vivo: possible process for aging of long-lived proteins. , 1981, Science.
[32] J. Eaton,et al. Spirohydantoin inhibitors of aldose reductase inhibit iron- and copper-catalysed ascorbate oxidation in vitro. , 1991, Biochemical pharmacology.
[33] V. Monnier,et al. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. , 1991, The Journal of biological chemistry.
[34] R. Dean,et al. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. , 1988, The Biochemical journal.